Frontage Holdings Corp
HKEX:1521

Watchlist Manager
Frontage Holdings Corp Logo
Frontage Holdings Corp
HKEX:1521
Watchlist
Price: 1.67 HKD 0.6%
Market Cap: 3.4B HKD
Have any thoughts about
Frontage Holdings Corp?
Write Note

Net Margin
Frontage Holdings Corp

2.4%
Current
8%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.4%
=
Net Income
6.1m
/
Revenue
260m

Net Margin Across Competitors

Country US
Market Cap 3.4B HKD
Net Margin
2%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 200.4B USD
Net Margin
14%
Country US
Market Cap 165.1B USD
Net Margin
18%
Country KR
Market Cap 67.9T KRW
Net Margin
24%
Country CH
Market Cap 38.3B CHF
Net Margin
9%
Country US
Market Cap 38.7B USD
Net Margin
22%
Country US
Market Cap 35.8B USD
Net Margin
9%
Country US
Market Cap 26.7B USD
Net Margin
21%
Country US
Market Cap 24B USD
Net Margin
17%
Country CN
Market Cap 163.2B CNY
Net Margin
21%
No Stocks Found

Frontage Holdings Corp
Glance View

Market Cap
3.4B HKD
Industry
Life Sciences Tools & Services

Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.

Intrinsic Value
2.65 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.4%
=
Net Income
6.1m
/
Revenue
260m
What is the Net Margin of Frontage Holdings Corp?

Based on Frontage Holdings Corp's most recent financial statements, the company has Net Margin of 2.4%.